Literature DB >> 34751908

Regulator of ribonuclease activity modulates the pathogenicity of Vibrio vulnificus.

Jaejin Lee1, Eunkyoung Shin1, Jaeyeong Park1, Minho Lee2, Kangseok Lee3.   

Abstract

RraA, a protein regulator of RNase E activity, plays a unique role in modulating the mRNA abundance in Escherichia coli. The marine pathogenic bacterium Vibrio vulnificus also possesses homologs of RNase E (VvRNase E) and RraA (VvRraA1 and VvRraA2). However, their physiological roles have not yet been investigated. In this study, we demonstrated that VvRraA1 expression levels affect the pathogenicity of V. vulnificus. Compared to the wild-type strain, the VvrraA1-deleted strain (ΔVvrraA1) showed decreased motility, invasiveness, biofilm formation ability as well as virulence in mice; these phenotypic changes of ΔVvrraA1 were restored by the exogenous expression of VvrraA1. Transcriptomic analysis indicated that VvRraA1 expression levels affect the abundance of a large number of mRNA species. Among them, the half-lives of mRNA species encoding virulence factors (e.g., smcR and htpG) that have been previously shown to affect VvrraA1 expression-dependent phenotypes were positively correlated with VvrraA1 expression levels. These findings suggest that VvRraA1 modulates the pathogenicity of V. vulnificus by regulating the abundance of a subset of mRNA species.
© 2021. The Microbiological Society of Korea.

Entities:  

Keywords:  RNase E; Vibrio vulnificus; VvRraA1; pathogenicity; virulence

Mesh:

Substances:

Year:  2021        PMID: 34751908     DOI: 10.1007/s12275-021-1518-5

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  46 in total

Review 1.  Biofilm formation: a clinically relevant microbiological process.

Authors:  R M Donlan
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

3.  Detecting Salmonella Type II flagella production by transmission electron microscopy and immunocytochemistry.

Authors:  Yoontak Han; Eun-Jin Lee
Journal:  J Microbiol       Date:  2019-11-23       Impact factor: 3.422

Review 4.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

5.  Lipoteichoic acids of lactobacilli inhibit Enterococcus faecalis biofilm formation and disrupt the preformed biofilm.

Authors:  Solmin Jung; Ok-Jin Park; A Reum Kim; Ki Bum Ahn; Dongwook Lee; Kee-Yeon Kum; Cheol-Heui Yun; Seung Hyun Han
Journal:  J Microbiol       Date:  2019-01-22       Impact factor: 3.422

6.  Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon.

Authors:  I C Blomfield; V Vaughn; R F Rest; B I Eisenstein
Journal:  Mol Microbiol       Date:  1991-06       Impact factor: 3.501

Review 7.  Molecular Pathogenesis of Vibrio vulnificus.

Authors:  Paul A Gulig; Keri L Bourdage; Angela M Starks
Journal:  J Microbiol       Date:  2005-02       Impact factor: 3.422

8.  RraAS2 requires both scaffold domains of RNase ES for high-affinity binding and inhibitory action on the ribonucleolytic activity.

Authors:  Jihune Heo; Daeyoung Kim; Minju Joo; Boeun Lee; Sojin Seo; Jaejin Lee; Saemee Song; Ji-Hyun Yeom; Nam-Chul Ha; Kangseok Lee
Journal:  J Microbiol       Date:  2016-09-30       Impact factor: 3.422

9.  Effects of null mutation of the heat-shock gene htpG on the production of virulence factors by Pseudomonas aeruginosa.

Authors:  Anna M Grudniak; Barbara Klecha; Krystyna I Wolska
Journal:  Future Microbiol       Date:  2017-12-04       Impact factor: 3.165

10.  RNase E in the γ-Proteobacteria: conservation of intrinsically disordered noncatalytic region and molecular evolution of microdomains.

Authors:  Soraya Aït-Bara; Agamemnon J Carpousis; Yves Quentin
Journal:  Mol Genet Genomics       Date:  2014-11-29       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.